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A B S T R A C T 
Objectives: To review the short-term outcome of 
endoscopic resection of superficial upper gastro-
intestinal lesions in Hong Kong.
Design: Historical cohort study. 
Setting: All Hospital Authority hospitals in Hong 
Kong.
Patients: This was a multicentre retrospective study 
of all patients who underwent endoscopic resection 
of superficial upper gastro-intestinal lesions between 
January 2010 and June 2013 in all government-
funded hospitals in Hong Kong. 
Main outcome measures: Indication of the 
procedures, peri-procedural and procedural 
parameters, oncological outcomes, morbidity, and 
mortality. 
Results: During the study period, 187 lesions in 
168 patients were resected. Endoscopic mucosal 
resection was performed in 34 (18.2%) lesions and 
endoscopic submucosal dissection in 153 (81.8%) 
lesions. The mean size of the lesions was 2.6 
(standard deviation, 1.8) cm. The 30-day morbidity 
rate was 14.4%, and perforations and severe 
bleeding occurred in 4.3% and 3.2% of the patients, 
respectively. Among patients who had dysplasia or 
carcinoma, R0 resection was achieved in 78% and 
the piecemeal resection rate was 11.8%. Lateral 
margin involvement was 14% and vertical margin 
involvement was 8%. Local recurrence occurred in 
9% of patients and 15% had residual disease. The 
2-year overall survival rate and disease-specific 
survival rate was 90.6% and 100%, respectively.
Conclusion: Endoscopic mucosal resection and 
Hospital Authority audit of the outcome of 
endoscopic resection of superficial upper  
gastro-intestinal lesions in Hong Kong
New knowledge added by this study
• Endoscopic mucosal resection and endoscopic submucosal dissection (ESD) were introduced in low-to-
moderate–volume hospitals with acceptable morbidity rates and excellent short-term survival.
• Other oncological outcomes were poorer than those observed in high-volume centres and more secondary 
procedures were required.
Implications for clinical practice or policy
• Better education in recognition of early upper gastro-intestinal neoplasms and pre-ESD workup is required. 
• Key personnel who perform ESD in individual hospitals should be identified for further advanced training.  
• A minimal level of competence should be established before beginners perform the procedure independently.
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ORIGINAL ARTICLECME
endoscopic submucosal dissection were introduced 
in low-to-moderate–volume hospitals with 
acceptable morbidity rates. The short-term survival 
was excellent. However, other oncological outcomes 
were poorer than those observed in high-volume 
centres and more secondary procedures were 
required. 
#  Endoscopic resection for upper gastro-intestinal lesions  # 
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內視鏡粘膜切除表淺性上消化道病變的結果： 
香港醫院管理局審核報告
張源斌、趙偉仁、陳小燕、張嘉姸、朱建民、高秀山、 
黎德榮、劉智偉、羅英傑、梁德麟、梁偉強、唐琼雄、曾兆熙
目的：回顧香港內視鏡粘膜切除表淺性上消化道病變的短期結果。
設計：歷史隊列研究。
安排：香港醫院管理局轄下的所有醫院。
患者：這是一項多間醫院參與的回顧性研究，對象包括於2010年1月
至2013年6月期間，因進行內視鏡粘膜切除表淺性上消化道病變而到
香港政府資助的醫院求診的所有病人。
主要結果測量：進行手術的原因、圍手術期和手術過程中的影響因
素、腫瘤控制結果、發病率和死亡率。
結果：研究期間共有168名患者（187例病變）接受切除術，其中34
例（18.2%）為內視鏡黏膜切除術，153例（81.8%）為內視鏡黏膜下
剝離切除術。病灶平均大小為2.6 cm（標準差1.8 cm）。30天患病率
為14.4%，4.3%的患者出現穿破，3.2%的患者有嚴重出血。有細胞異
生或腫瘤的患者中，78%達至R0（根治性切除），11.8%進行分塊切
除。14%累及水平緣，8%累及垂直緣。患者中，9%有局部復發，15%
因殘留癌細胞而有復發。兩年總存活率和疾病特定存活率分別為
90.6%和100%。
結論：在低至中收容量醫院進行內視鏡黏膜切除術和內視鏡黏膜下剝
離術的發病率屬可接受範圍。短期存活率極佳。然而，與高收容量醫
院比較，低至中收容量醫院的術後腫瘤控制結果較差，跟進手術的次
數也較多。
Introduction
The use of endoscopic resection in the treatment 
of superficial gastro-intestinal neoplasms is gaining 
popularity worldwide.1-11 Endoscopic mucosal 
resection (EMR) and endoscopic submucosal 
dissection (ESD) are the key endoscopic methods 
pioneered in Japan and Korea for resection of 
these lesions.1-7 Early gastric or oesophageal 
neoplasms are associated with a low rate of lymph 
node metastasis and endoscopic resection of these 
neoplasms has been shown to be associated with a 
low rate of morbidity and high long-term survival.6,7 
Nevertheless, the adoption of these techniques 
outside high-volume countries has been slow, as 
the recognition of early gastric and oesophageal 
neoplasms is difficult and the procedures required 
for endoscopic resection are technically demanding 
and have a long learning curve.8-14 
 In Hong Kong, an increased awareness and 
recognition of early gastro-intestinal neoplasms 
have resulted in greater frequency of diagnosis of 
these lesions. Hence advanced endoscopic resection 
procedures such as EMR or ESD are also being 
performed increasingly. However, the scope of these 
services provided by government-funded hospitals 
operated by the Hospital Authority of Hong Kong 
has not been previously defined. In addition there 
are limited data on the outcome of these advanced 
endoscopic procedures outside high-volume centres 
of Japan and Korea. 
 The aim of the current study was to perform 
a region-wide audit of the short-term clinical 
and oncological outcomes of EMR and ESD for 
superficial upper gastro-intestinal neoplasms in all 
government-funded hospitals in Hong Kong.
Methods
This was a Hong Kong–wide retrospective review 
commissioned by the Hospital Authority of Hong 
Kong of all patients who underwent EMR or ESD for 
superficial upper gastro-intestinal lesions between 
January 2010 and June 2013 in 12 government-
funded hospitals. Patients were identified using 
the Clinical Data Analysis and Reporting System 
(CDARS) based on their diagnostic and procedural 
coding (9th edition of the International Classification 
of Diseases). The CDARS is a computer-based 
administration database that records all the 
diagnostic and procedural coding of admitted 
patients. Patient data were retrieved and reviewed 
manually through the system. Data were recorded 
for indication of the procedures, peri-procedural and 
procedural parameters, oncological outcomes, and 
morbidity and mortality. The study was performed 
according to the Declaration of Helsinki.
Endoscopic mucosal resection or endoscopic 
submucosal dissection procedure
All patients who underwent EMR or ESD of the 
oesophagus, stomach, and duodenum were included 
in the study. To differentiate these patients from 
those that received simple polypectomy, EMR was 
defined as the act of performing mucosectomy 
with prior injection of a cushioning fluid into the 
submucosa to hasten removal of the lesions. It was 
acknowledged that EMR could be performed by a 
variety of methods but this review did not attempt 
to sub-classify patients according to the different 
techniques used.1 On the other hand, ESD was 
defined as a more refined form of mucosectomy that 
involved submucosal injection of a cushioning fluid, 
circumferential incision of the mucosa, followed 
by dissection of the submucosal tissue to free the 
lesion away from surrounding tissue. The type of 
endoscopic knives used for mucosal incision and 
submucosal dissection were also recorded.
 The outcomes of EMR and ESD were assessed 
clinically and oncologically. 
Assessment of clinical outcomes
Compared with conventional polypectomy, ESD is a 
technically demanding procedure that is associated 
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with an increased risk of complications. In particular, 
the risk of perforation and bleeding are heightened 
in inexperienced operators.13,14 In the current study, 
intra-procedural and post-procedural complications 
were recorded and factors alluding to development 
of these complications were also reviewed. 
Assessment of oncological outcomes
To determine whether EMR or ESD can provide 
adequate oncological clearance for neoplastic 
lesions, assessment of long-term survival is essential. 
However, since EMR or ESD procedures have been 
performed in Hong Kong for only a short period of 
time, such  assessment was not possible. Thus, the 
adequacy of oncological control of EMR or ESD was 
based on completeness of resection as judged during 
the procedure, presence of margin involvement 
(lateral and deep), the need for piecemeal resection, 
and recurrence rates. En-bloc resection was defined 
as resection of the tumour in one piece. R0 resection 
was defined as resection of the tumour with clear 
lateral and vertical margins. R1 resection was defined 
as microscopic involvement of the margins. R2 
resection was defined as macroscopic involvement 
of margins as noted during endoscopy. Local 
recurrence was defined as recurrent cancer detected 
at the primary resection site during follow-up 
oesophagogastroduodenoscopy when pathological 
review of the ESD specimen revealed no tumour on 
the lateral and vertical margins.
Statistical analyses
Statistical analyses were done mainly using 
descriptive analysis. The predictors of morbidity 
and local recurrences were analysed by multivariate 
logistic regression analysis using the following factors: 
sex, American Society of Anesthesiologists grading, 
presence of neoplastic lesions (adenoma, dysplasia, 
carcinoma), ESD performed as a staging procedure, 
the need for piecemeal resection, pathological size, 
lateral and vertical margin involvement, depth 
of pathological invasion, R0 resection, and the 
institution volume of ESD. The 2-year overall and 
disease-specific survivals were calculated using 
the Kaplan-Meier estimator. A two-sided P value 
of <0.05 was considered statistically significant. 
Statistical analyses of data were performed using the 
Statistical Package for the Social Sciences (Windows 
version 20.0; SPSS Inc, Chicago [IL], US). 
Results
During the study period, 187 lesions in 168 patients 
were resected. The patient demographics are shown 
in Table 1. The mean (± standard deviation) age of 
patients was 61.9 ± 14.3 years and 61.3% were male. 
Overall, EMR was performed in 34 (18.2%) lesions 
and ESD in 153 (81.8%) lesions for dysplasia or 
carcinoma with the majority of lesions located in 
the stomach (132 lesions, 70.6%), followed by the 
oesophagus (43 lesions, 23%) and the duodenum 
(12 lesions, 6.4%). The distribution in the numbers 
of the procedures among various hospitals is shown 
in Figure a.
TABLE 1.  Background demographics of patients who underwent endoscopic mucosal 
resection or endoscopic submucosal dissection
Demographics Data (168 patients; 187 lesions)*
Age (years) 61.9 ± 14.3
Male / female 103 (61.3) / 65 (38.7) 
Smoker / drinker 23 (13.7) / 17 (10.1) 
ASA grading
I / II / III / IV 45 (26.8) / 65 (38.7) / 45 (26.8) / 13 (7.7) 
Oesophagus / stomach / duodenum 43 (23) / 132 (70.6) / 12 (6.4) 
EMR 34 (18.2)
Oesophagus / stomach / duodenum 12 / 16 / 6
ESD 153 (81.8)
Oesophagus / stomach / duodenum 31 / 116 / 6
Location† 
Stomach (L / M / U / A) 95 / 16 / 19 / 2
Oesophagus (L / M / U / A) 8 / 20 / 14 / 1
Pre-procedural indications
Oesophagus
Dysplasia 29
Leiomyoma 6
Carcinoma 5
Oesophageal polyp 2
GIST 1
Stomach
Dysplasia 41
Hyperplastic polyp 26
Adenocarcinoma 22
GIST 13
Adenomatous polyp 10
Neuroendocrine tumour 4
Submucosal tumours 4
Miscellaneous conditions 12
Duodenum
Adenomatous polyp 4
Neuroendocrine tumour 4
Hyperplastic polyp 1
Non-specific polyp 3
Abbreviations:  ASA = American Society of Anesthesiologists; EMR = endoscopic 
mucosal resection; ESD = endoscopic submucosal dissection; GIST = gastro-intestinal 
stromal tumour
* Data are shown in mean ± standard deviation, No. (%), or No.
† L = lower; M = middle; U = upper ;  A = anastomosis
#  Endoscopic resection for upper gastro-intestinal lesions  # 
227Hong Kong Med J  ⎥  Volume 21 Number 3  ⎥  June 2015  ⎥  www.hkmj.org
 The clinical outcomes of the procedures 
are shown in Table 2. General anaesthesia with 
tracheal intubation was required for the majority of 
procedures (n=148, 79.1%). The procedural times 
were recorded in 50 (26.7%) procedures only and 
were not representative of the actual time required 
for the procedures. The mean size of the lesions was 
2.6 ± 1.8 cm. The 30-day morbidity rate was 14.4%. 
Intra-procedural complications occurred in 13 
(7.0%) procedures, with one procedure having both 
bleeding and perforation. Perforations occurred 
in eight (4.3%) procedures and all were controlled 
with endoscopic clipping. Severe bleeding requiring 
endoscopic clipping or transfusion occurred in 
six (3.2%) procedures. One procedure required 
conversion to open surgery due to uncontrolled 
bleeding. Post-procedural complications occurred 
in 14 (7.5%) procedures; the most common causes 
of which were bleeding (4.3%), stricture formation 
(1.6%), and perforations (1.1%). All post-procedural 
bleeding and stricture formation were managed 
endoscopically. The procedures having perforation 
were managed conservatively. No patients had post-
procedural mortality. The mean hospital stay was 3.7 
± 3.1 days. Haemoglobin level was checked on the 
first post-procedural day in 116 (62%) procedures. 
Proton pump inhibitors were prescribed to 171 
(91.4%) procedures; of these, 93 (80.2%) were 
administered to ESD in the stomach. No difference 
in size of lesions, hospital stay, or morbidities was 
observed between university– and non-university–
affiliated hospitals.
 The types of knives used for mucosal incision 
included the Dual knife (35.8%; KD-650U, Olympus 
Co Ltd, Tokyo, Japan), the triangular tip knife (14.4%; 
KD-640L, Olympus Co Ltd, Tokyo, Japan), the 
needle knife (8%; KD-1L-1, Olympus Co Ltd, Tokyo, 
Japan), the insulated tip (IT2) knife (7%; KD-610L, 
Olympus Co Ltd, Tokyo, Japan), and the Hybrid 
knife (3.7%; ERBE, Tübingen, Germany). Knives used 
for submucosal dissection included the Dual knife 
FIG.  (a) The distribution of procedures among hospitals in Hong Kong; ESDs in hospitals 2 and 3 were performed by the same doctors and were 
considered as one group. (b) The 2-year overall survival of patients with adenoma, dysplasia, or carcinoma
Abbreviations: EMR = endoscopic mucosal resection; ESD = endoscopic submucosal dissection
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TABLE 2.  Assessment of clinical outcome
Clinical outcome Data (168 patients; 
187 lesions)*
General anaesthesia / conscious 
sedation
148 (79.1) / 39 (20.9)
Procedural time (mins)† 31.3 ± 26.3
Size of lesions (cm) 2.6 ± 1.8
30-Day mortality 0
30-Day morbidity 27 (14.4)
Intra-procedural complications 13 (7.0)‡ 
Bleeding 6 (3.2)
Perforation 8 (4.3)
Post-procedural complications 14 (7.5)
Bleeding 8 (4.3)
Perforation 2 (1.1)
Stricture 3 (1.6)
Bronchospasm 1 (0.5)
Hospital stay (days) 3.7 ± 3.1
* Data are shown in mean ± standard deviation or No. (%)
† Only the time for 50 procedures were recorded
‡ One case had both bleeding and perforation
  #  Teoh et al #
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(48%; KD-650U, Olympus Co Ltd), the insulated tip 
(IT2) knife (24.6%; KD-610L, Olympus Co Ltd), the 
triangular tip knife (11.2.%; KD-640L, Olympus Co 
Ltd), and the Hybrid knife (4.3%; ERBE).
 The oncological outcome of the procedures 
is shown in Table 3. In 22 (11.8%) lesions, en-bloc 
resection was not possible and the lesions had to 
be resected in piecemeal. Among patients having 
adenoma, dysplasia, or carcinoma (n=100), R0 
resection was achieved in 78%. In 7% of the patients, 
pre-procedural investigations were inconclusive on 
the feasibility of endoscopic resection and ESD was 
performed as a staging procedure. Lateral margin 
involvement occurred in 14 (14%) procedures and 
vertical margin involvement occurred in eight (8%) 
procedures. Local recurrences occurred in nine 
(9%) patients and five were treated by further ESD. 
Residual disease was present in 15 (15%) patients, 
four due to failure to complete ESD and 11 due 
to margin involvement. Of these 15 patients with 
residual disease,  complete resection was achieved 
in eight during salvage surgical resection, two 
patients underwent repeat endoscopic resection, 
two underwent radiofrequency ablation, and three 
refused treatment. The mean follow-up time of 
patients was 20.6 ± 10.8 months and the 2-year overall 
survival rate and disease-specific survival rate was 
90.6% and 100%, respectively (Fig b). Overall, 38.5% 
of patients were followed up for at least 2 years. No 
differences in oncological outcomes were observed 
between university– and non-university–affiliated 
hospitals.
 The predictors of morbidity in patients who 
received endoscopic resection were then analysed 
with multivariate logistic regression (Table 4). 
Specimen size of ≥5 cm (P=0.001), the need for 
piecemeal resection (P=0.032), and pathological 
invasion to the submucosa or deeper (P=0.042) were 
independent predictors of morbidity. The predictors 
for local recurrences were also analysed: the need 
for piecemeal resection was the only independent 
predictor (P=0.011; Table 5).
Discussion
Using a hospital admission database, the outcome 
for patients who underwent endoscopic resection of 
superficial upper gastro-intestinal neoplasms among 
12 government-funded hospitals in Hong Kong was 
reviewed. The total number of procedures performed 
was higher than expected and the procedures were 
associated with a low risk of morbidity. Nonetheless 
there may be room for improvement in the 
oncological outcome, particularly in terms of rates 
of margin involvement and the number of patients 
with residual disease. The predictors of morbidity 
and local recurrence were in line with those reported 
from high-volume centres and the 2-year survival of 
patients who had adenoma, dysplasia, or carcinoma 
TABLE 3.  Assessment of oncological outcome
Oncological outcome No. (%) of lesions (n=187)*
Pathological diagnosis
Oesophagus 
Squamous cell carcinoma 7
Adenocarcinoma 3
Severe dysplasia 10
Moderate dysplasia 6
Mild dysplasia 3
Leiomyoma 8
Hyperplastic polyp 1
Benign mucosa 5
Stomach 
Adenocarcinoma 21
Severe dysplasia 14
Moderate dysplasia 9
Mild dysplasia 16
Adenomatous polyp 11
Hyperplastic polyp 26
Inflammatory fibroblastic polyp 3
Neuroendocrine tumour 5
Gastro-intestinal stromal tumour 4
Schwannoma 1
Miscellaneous benign conditions 22
Duodenum
Severe dysplasia 1
Neuroendocrine tumour 3
Adenomatous polyp 1
Brunner’s gland adenoma 4
Inflammatory pseudotumour 1
Ectopic gastric mucosa 2
Piecemeal resection 22 (11.8)
R0 resection (n=100) 78 (78)
Oesophagus / gastric 24 (30.8) / 53 (67.9) / 1 (1.3) 
Staging procedure (n=100) 7 (7)
Lateral margin involvement (n=100)
Focal (oesophagus / gastric / duodenum) 9 (9) [3 / 6 / 0]
Gross (oesophagus / gastric / duodenum 5 (5) [1 / 4 / 0])
Not assessed 8 (8)
Vertical margin involvement (n=100)
Focal (oesophagus / gastric / duodenum) 4 (4) [0 / 4 / 0]
Gross (oesophagus / gastric / duodenum) 4 (4) [0 / 4 / 0]
Not assessed 8 (8)
Residual disease 15 (15)
Local recurrence 9 (9)
* Data are shown in No. or No. (%)
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was excellent following endoscopic resection.
 The adoption of ESD outside Japan and Korea 
has been slow.5,8,15-18 The reported studies were 
mostly small series and the results were variable. In 
four European and two South-East Asian studies, the 
number of patients included was between 23 and 70, 
the en-bloc resection rate ranged from 25% to 100% 
and morbidity 0% to 24%. These results contrast 
with those obtained from Japan and Korea. In the 
stomach, the rate of en-bloc resection was 94.9% 
to 95.3% and piecemeal resection was 4.1%. The 
risk of bleeding was 1.8% to 16.2% and perforation 
was 1.2% to 4.5%. The risk of recurrence was less 
than 1% and the 3- and 5-year overall survival rates 
were 98.4% and 97.1% respectively.6,7 These results 
reflect the difficulty of introducing a technically 
demanding ESD programme in low-to-medium 
volume localities outside Japan and Korea.19 The 
reasons for poorer clinical and oncological outcomes 
may be explained by a combination of factors. These 
include the early experience and learning curve 
issues, technical difficulties leading to the need for 
piecemeal resection, and failure to recognise tumour 
margins.
 The current study is the largest non-Japanese 
and non-Korean report on the outcomes of ESD. The 
results illustrate that an acceptable en-bloc resection 
rate and morbidity rate can be achieved in low-to-
medium–volume hospitals. The introduction of 
endoscopic resection techniques in Hong Kong is 
in its infancy with many challenges similar to those 
described in western literature.20-22 The emphasis in 
our region, however, was not just on the technical 
performance of ESD but also the ability to detect 
and diagnose these lesions. In 2011, a total of 1101 
new cases of gastric cancer were diagnosed in Hong 
Kong but the percentage of cases that were amenable 
to endoscopic resection is unknown.23 Based on the 
findings of this study, the percentages are likely to 
have been much less than 10%. This figure contrasts 
significantly with those reported from Spain (20%) 
and Japan (53%).24,25 Hence, measures to further 
improve the early diagnosis of upper gastro-
intestinal malignancies are needed. Key personnel 
to perform ESD in individual hospitals should be 
identified and receive intensive training in screening 
endoscopy to improve detection of early lesions.26 
These individuals should attend local workshops 
TABLE 4.  Multivariate analysis of predictors to morbidity
TABLE 5.  Multivariate analysis of predictors to local recurrence
Variable Odds ratio (95% CI) P value
Specimen size ≥5 cm 10.76 (2.51-43.77) 0.001
Piecemeal resection 7.80 (1.20-50.78) 0.032
Pathological invasion to submucosa or deeper 5.12 (1.06-24.65) 0.042
Neoplastic lesions (adenoma, dysplasia, or carcinoma) 4.21 (0.95-18.60) 0.058
Sex 1.10 (0.34-3.52) 0.878
ASA grading 0.79 (0.16-18.63) 0.450
ESD performed as staging procedure 1.72 (0.16-18.63) 0.657
Lateral margin involvement 1.62 (0.57-4.65) 0.368
Vertical margin involvement 0.76 (0.27-2.13) 0.594
Institution volume of ESD procedures ≥20 0.76 (0.21-42.65) 0.682
Variable Odds ratio (95% CI) P value
Piecemeal resection 17.47 (1.94-157.72) 0.011
Specimen size ≥5 cm 6.08 (0.94-39.37) 0.058
Pathological invasion to submucosa or deeper 3.27 (0.49-21.95) 0.223
Neoplastic lesions (adenoma, dysplasia, or carcinoma) 2.12 (0.42-10.62) 0.363
Sex 0.67 (0.19-2.41) 0.537
ASA grading 0.93 (0.46-1.90) 0.846
Institution volume of ESD procedures ≥20 1.98 (0.47-8.32) 0.351
Abbreviations:  ASA = American Society of Anesthesiologists; CI = confidence interval; ESD = endoscopic submucosal dissection
Abbreviations:  ASA = American Society of Anesthesiologists; CI = confidence interval; ESD = endoscopic submucosal dissection
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and clinical attachments at high-volume centres in 
Japan and Korea to acquire such skills. Enhanced 
endoscopic imaging systems (narrow band imaging, 
flexible spectral imaging colour enhancement, or 
autofluorescence imaging) that may improve the ease 
of diagnosing early upper gastro-intestinal lesions 
should also be obtained by those hospitals interested 
in developing the technique and these should be 
supported by the government on a regional scale.27-29 
The use of population-based screening programmes 
in our locality may not be justified because of the 
moderate incidence of upper gastro-intestinal 
cancers, but studies to evaluate screening of high-
risk groups may be justified.30,31 Better recognition 
of early upper gastro-intestinal neoplasms not only 
increases the detection rates but may also allow more 
accurate pre-ESD assessment and improve the rates 
of margin involvement and oncological outcomes.
 It is acknowledged that ESD remains a 
technically demanding procedure that is associated 
with risk of perforation and bleeding. To master such 
skills, the surgeon must be familiar not only with 
the ESD procedure, but also with the methods used 
to treat complications. In addition, the difficulty of 
ESD depends on the organ involved, as well as the 
location within that organ.32,33 Thus, in high-volume 
centres, learning of ESD is usually done in a stepwise 
approach, starting from easy small lesions located at 
the antrum of the stomach and progressing to more 
difficult lesions or lesions located in other parts of 
the gastro-intestinal tract.34,35 The number required 
for mastering the technique is 20 to 40 procedures 
in each location. These numbers are unlikely to be 
attainable within a short period of time in Hong 
Kong and most western countries. Hence, each 
locality will need to decide on the most appropriate 
training strategy to overcome the learning curve: 
this will likely involve intensive training with the use 
of animal models, apprenticeship with local experts, 
and overseas training in high-volume centres.13,20,24 
It may also be beneficial to the region to restrict 
the performance of ESD to a few key personnel in 
the main institutions and once they are proficient, 
involve other endoscopists in the process.
 To further improve the outcome of endoscopic 
resection of upper gastro-intestinal lesions in 
Hong Kong, a number of measures should be 
implemented. The establishment of a task force on 
endoscopic diagnosis and treatment of early gastro-
intestinal cancers with regular training should 
be considered. A local standard in endoscopic 
reporting and pathological examination is required 
as these assessments of early upper gastro-intestinal 
neoplasms are unique and pivotal to guiding 
treatment. A ‘best practice’ guideline for performing 
ESD and the provision of pre- and post-ESD care 
should be established to provide a benchmark for 
future audits. 
 There were a number of limitations to the 
current study. First, patients included in the study 
were identified using CDARS based on the diagnosis 
and procedural coding. There is a risk of unidentified 
procedures if they were incorrectly coded. Also, 
those procedures that were performed outside the 
Hospital Authority hospitals could not be accounted 
for. Second, since this is a retrospective review, some 
outcome parameters might not have been properly 
defined or available for all patients. Finally, since 
there is no standardised reporting system in Hong 
Kong for ESD or EMR and pathological assessment, 
there was a risk of information bias during extraction 
of the data. 
Conclusion
The introduction of ESD in Hong Kong is still in 
its infancy; EMR and ESD were introduced in low-
to-moderate–volume hospitals with acceptable 
morbidity rates. The short-term survival was 
excellent. Nonetheless, other oncological outcomes 
were poorer than those observed in high-volume 
centres and more secondary procedures were 
required. 
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